Lobular carcinoma arising in fibroadenoma of the breast.

Abstract:

:Lobular carcinoma may arise within the epithelial component of fibroadenoma of the breast, as evidenced by 5 cases reported from the files of the Mayo Clinic and 21 cases cited in the literature. The 5 cases reported here occurred in a series of 4000 cases of fibroadenoma during a 43-year period. Lobular carcinoma is the more frequent type to be seen in fibroadenoma (in 22 of 26 cases); it usually develops in situ. Extra-adenomatous carcinoma of the ipsilateral breast was identified in 11 of 26 cases, and 3 cases of contralateral carcinoma were noted in the entire series. Thus, lobular carcinoma arising within the epithelial component of a fibroadenoma has biological features similar to the behavior of lobular carcinoma of the breast in general. The prognosis has been favorable; lesions are usually encountered early; in only 2 of 26 cases were there axillary metastases.

journal_name

Cancer

journal_title

Cancer

authors

Buzanowski-Konakry K,Harrison EG Jr,Payne WS

doi

10.1002/1097-0142(197502)35:2<450::aid-cncr2820350

subject

Has Abstract

pub_date

1975-02-01 00:00:00

pages

450-6

issue

2

eissn

0008-543X

issn

1097-0142

journal_volume

35

pub_type

杂志文章

相关文献

CANCER文献大全
  • Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.

    abstract:BACKGROUND:Cyclooxygenase 2 (COX-2)-dependent signaling represents a potential mechanism of resistance to therapy with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. This is mediated in part through an EGFR-independent activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regul...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.29480

    authors: Reckamp KL,Koczywas M,Cristea MC,Dowell JE,Wang HJ,Gardner BK,Milne GL,Figlin RA,Fishbein MC,Elashoff RM,Dubinett SM

    更新日期:2015-09-15 00:00:00

  • Irradiation and immunotherapy: From concept to the clinic.

    abstract::In recent years, an increased understanding of T-cell-regulatory mechanisms has led to the development of a novel class of immune-checkpoint inhibitors that have robust clinical activity against a broad array of malignancies-even those that historically were not believed to be sensitive to immune therapy. With this, t...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.29889

    authors: Salama AK,Postow MA,Salama JK

    更新日期:2016-06-01 00:00:00

  • Thymic carcinoid. A histologic, immunohistochemical, and ultrastructural study of 12 cases.

    abstract::Twelve cases of thymic carcinoid were studied by electron microscopy and immunohistochemistry. Clinically, all of them presented either as asymptomatic, radiographically detected mediastinal masses or as neoplasms producing symptoms of thoracic structural displacement or Cushing's syndrome. By light microscopic examin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840201)53:3<475::aid-cncr28205

    authors: Wick MR,Scheithauer BW

    更新日期:1984-02-01 00:00:00

  • Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.

    abstract:BACKGROUND:The effect on prognosis of adding imatinib mesylate to the treatment of patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) has not been explored fully. The objective of the current study was to evaluate the benefit of adding imatinib to the treatment sequence of patients w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11665

    authors: Kantarjian H,O'Brien S,Cortes J,Shan J,Giles F,Garcia-Manero G,Verstovsek S,Faderl S,Rios MB,Talpaz M

    更新日期:2003-10-01 00:00:00

  • Comparison of tartrate-resistant acid phosphatase in normal mouse tissues to that in the reticulum cells of leukemic reticuloendotheliosis.

    abstract::A strong activity of the tartrate-resistant acid phosphatase, isoenzyme 5b, was observed in mouse spleen. The enzyme of the mouse spleen had similar electrophoretic mobility and related antigenicity to that of the reticulum cells of leukemic reticuloendotheliosis. Enzyme histochemical studies showed many non-phagocyti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810215)47:4<710::aid-cncr28204

    authors: Kuehler D,Lam KW,Yam LT

    更新日期:1981-02-15 00:00:00

  • Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.

    abstract::Based on laboratory studies showing enhanced cytotoxicity of floxuridine (FUDR) when used with high doses of leucovorin (LV), a pilot study of FUDR and LV through an implantable pump was initiated for the treatment of hepatic metastases from colorectal cancer. The highest dose of LV that could be administered, taking ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900601)65:11<2446::aid-cncr282

    authors: Kemeny N,Cohen A,Bertino JR,Sigurdson ER,Botet J,Oderman P

    更新日期:1990-06-01 00:00:00

  • Prognostic ability of simplified nuclear grading of renal cell carcinoma.

    abstract:BACKGROUND:The Fuhrman grading system is an established predictor of survival in patients with renal cell carcinoma (RCC). The predictive accuracy of various Fuhrman grading schemes was tested with the intent of improving the prediction of RCC-specific survival (RCC-SS). METHODS:The analyses targeted 5453 patients fro...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.22463

    authors: Rioux-Leclercq N,Karakiewicz PI,Trinh QD,Ficarra V,Cindolo L,de la Taille A,Tostain J,Zigeuner R,Mejean A,Patard JJ

    更新日期:2007-03-01 00:00:00

  • Lymphocyte subpopulations in patients with multiple primary tumors.

    abstract:BACKGROUND:Cancer patients with single tumors live longer today due to earlier detection and improved treatment methods. For this reason, the authors see more patients who develop a second primary tumor. The etiology of the second tumor can be the same as the first, whether treatment-induced or unknown. The prognoses o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990501)85:9<2073::aid-cn

    authors: Robinson E,Segal R,Struminger L,Faraggi D,El'ad-Yarum R,Mekori T

    更新日期:1999-05-01 00:00:00

  • Parametrial implant in Stage III B cancer of the cervix. III. A five-year study.

    abstract::Since 1975, the Department of Radiation Therapy, University of Maryland Hospital initiated a policy of supplementing the dose to the affected parametrium by using radium needles implants in conjunction with a protruding tandem preferably, or Manchester ovoid in the case of absence of the lower segment of the uterus. T...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830815)52:4<748::aid-cncr28205

    authors: Prempree T

    更新日期:1983-08-15 00:00:00

  • Implications of false-positive results for future cancer screenings.

    abstract:BACKGROUND:False-positive cancer screening results may affect a patient's willingness to obtain future screening. METHODS:The authors conducted logistic regression analysis of 450,484 person-years of electronic medical records (2006-2015) in 92,405 individuals aged 50 to 75 years. Exposures were false-positive breast,...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31271

    authors: Taksler GB,Keating NL,Rothberg MB

    更新日期:2018-06-01 00:00:00

  • Lymphoplasmacytic lymphoma. Report of a case with three monoclonal proteins derived from a single neoplastic clone.

    abstract::The unique case of a 60-year-old patient with a non-Hodgkin's B-cell lymphoma of the lymphoplasmacytic type and three associated monoclonal proteins, is described. The patient also exhibited various autoimmune phenomena that were consistent with the diagnoses of Sjögren's syndrome and autoimmune thyroiditis. The evolu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860501)57:9<1794::aid-cncr2820

    authors: Berg AR,Weisenburger DD,Linder J,Armitage JO

    更新日期:1986-05-01 00:00:00

  • Bone turnover and biochemical markers in malignancy.

    abstract::There are three principal disturbances in bone remodelling that occur in neoplasia affecting the skeleton. The first is an increase in bone turnover that in solid tumors may be confined to sites of metastases or be a generalized phenomenon, most likely related to the secretion of parathyroid hormone-related protein. I...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(sici)1097-0142(19971015)80:8+<1538::aid-c

    authors: Kanis JA,McCloskey EV

    更新日期:1997-10-15 00:00:00

  • Outcome of palliative urinary diversion in the treatment of advanced malignancies.

    abstract:BACKGROUND:It is unclear whether palliative endourologic or percutaneous urinary diversion in the treatment of advanced cancer provides significant improvement in quality or duration of life. The purpose of this study was to evaluate survival and performance status after endourologic palliative urinary diversion in pat...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990215)85:4<998::aid-cnc

    authors: Shekarriz B,Shekarriz H,Upadhyay J,Banerjee M,Becker H,Pontes JE,Wood DP Jr

    更新日期:1999-02-15 00:00:00

  • Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia.

    abstract:BACKGROUND:Nilotinib is a potent, second-generation inhibitor of BCR-ABL1 tyrosine kinase and has been approved as frontline and salvage therapy for patients with chronic-phase chronic myeloid leukemia (CP-CML). METHODS:In this single-institution, phase 2 study, 122 patients with newly diagnosed CP-CML received niloti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32623

    authors: Masarova L,Cortes JE,Patel KP,O'Brien S,Nogueras-Gonzalez GM,Konopleva M,Verstovsek S,Garcia-Manero G,Ferrajoli A,Kadia TM,Ravandi-Kashani F,Borthakur G,DellaSala S,Estrov Z,Jabbour EJ,Kantarjian HM

    更新日期:2020-04-01 00:00:00

  • Prognostic significance of mast cells in soft tissue sarcoma.

    abstract::We counted the number of toluidine blue positive mast cells within and around the tumor in 44 patients with soft tissue sarcomas (STS). Irrespective of their histologic types, these cases were broadly divided into the following two groups: (1) low count (less than 20 mast cells/10 high-power fields [HPF]) and (2) high...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19881201)62:11<2416::aid-cncr282

    authors: Ueda T,Aozasa K,Tsujimoto M,Yoshikawa H,Kato T,Ono K,Matsumoto K

    更新日期:1988-12-01 00:00:00

  • Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma.

    abstract:BACKGROUND:Multiple cell-signaling ligands and receptors-including vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), endothelial growth factor (EGF), v-akt murine thymoma viral oncogene homolog (AKT), platelet-derived growth factor (PDGF), mitogen-activated protein kinase (MAPK), and 70-kilod...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24562

    authors: Abdeen A,Chou AJ,Healey JH,Khanna C,Osborne TS,Hewitt SM,Kim M,Wang D,Moody K,Gorlick R

    更新日期:2009-11-15 00:00:00

  • A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006.

    abstract:BACKGROUND:The use of docetaxel prolongs survival for patients with castrate-resistant prostate cancer (CRPC). Inhibition of vascular endothelial growth factor (VEGF) with bevacizumab may further enhance the antitumor effect of docetaxel and estramustine in patients with CRPC. METHODS:This cooperative group trial enro...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.25421

    authors: Picus J,Halabi S,Kelly WK,Vogelzang NJ,Whang YE,Kaplan EB,Stadler WM,Small EJ,Cancer and Leukemia Group B.

    更新日期:2011-02-01 00:00:00

  • Ultrastructure of chondroid syringoma: role of the myoepithelial cell in the development of the mixed tumor of the skin and soft tissues.

    abstract::The ultrastructure of a chondroid syringoma is described. The tumor nests are formed by clumps, solid cords and tubular structures distributed diffusely throughout a stroma of varying density. Two different types of cells form this tumor: dark cells forming the inner layer of the tubuloalveolar and ductal structures a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197907)44:1<148::aid-cncr2820440

    authors: Varela-Durán J,Díaz-Flores L,Varela-Núnez R

    更新日期:1979-07-01 00:00:00

  • HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.

    abstract:BACKGROUND:Human epidermal growth factor receptor 2 (HER2) is a therapeutic target in patients with esophageal adenocarcinoma (EAC), with gene amplification used as a selection criterion for treatment, although to the authors' knowledge the concordance between amplification and HER2 protein expression remains undefined...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28435

    authors: Yoon HH,Sukov WR,Shi Q,Sattler CA,Wiktor AE,Diasio RB,Wu TT,Jenkins RB,Sinicrope FA

    更新日期:2014-02-01 00:00:00

  • Reliability of computer image analysis of pigmented skin lesions of Australian adolescents.

    abstract:BACKGROUND:The diagnosis of melanomas at an early stage is associated with improved survival, so the recognition of changes in pigmented skin lesions over time is important. We have developed a computer imaging system with the aim of assisting clinicians in differentiating early melanomas from benign pigmented skin les...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0142(19960715)78:2<252::AID-CNC

    authors: Aitken JF,Pfitzner J,Battistutta D,O'Rourke PK,Green AC,Martin NG

    更新日期:1996-07-15 00:00:00

  • Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.

    abstract::Fifty-four patients with advanced squamous, large-cell or adeno-carcinoma of the lung were treated with a three drug regimen of high-dose cisplatin, vindesine and a four-day bleomycin infusion (CVB). All patients had measurable disease; none had previously received chemotherapy. Of 52 patients evaluable for response, ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830315)51:6<1050::aid-cncr2820

    authors: Itri LM,Gralla RJ,Kelsen DP,Chapman RA,Casper ES,Braun DW Jr,Howard JE,Golbey R,Heelan RT

    更新日期:1983-03-15 00:00:00

  • Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.

    abstract::A bolus intravenous dose of 5-fluorouracil of 600 mg/M2 was added exactly 1 hour after methotrexate administration in an established combination program including bleomycin and cisplatin for advanced squamous cell cancer of the head and neck. Results were no better than those observed previously with the three drugs, ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860215)57:4<706::aid-cncr28205

    authors: Vogl SE,Komisar A,Kaplan BH,Engstrom PF,Kasule OH,Stolbach L,Lerner H,Muggia F

    更新日期:1986-02-15 00:00:00

  • Multivariate analysis for histologic prognostic factors in soft tissue sarcomas.

    abstract::To investigate histologic prognostic factors in soft tissue sarcomas (STS), multivariate analysis was performed on 236 patients with complete clinical information. These included 141 males and 95 females with an age range from 1 to 85 years (median, 47.6 years). Histologically, malignant fibrous histiocytoma (33.5%) w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880901)62:5<994::aid-cncr28206

    authors: Tsujimoto M,Aozasa K,Ueda T,Morimura Y,Komatsubara Y,Doi T

    更新日期:1988-09-01 00:00:00

  • Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831.

    abstract:BACKGROUND:Increased soluble human epidermal growth factor receptor 2 (sHER2) is an indicator of a poor prognosis in HER2-positive metastatic breast cancer. In this study, the authors evaluated levels of sHER2 during treatment and at the time of disease recurrence in the adjuvant North Central Cancer Treatment Group N9...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.28130

    authors: Moreno-Aspitia A,Hillman DW,Dyar SH,Tenner KS,Gralow J,Kaufman PA,Davidson NE,Lafky JM,Reinholz MM,Lingle WL,Kutteh LA,Carney WP,Dueck AC,Perez EA

    更新日期:2013-08-01 00:00:00

  • Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients.

    abstract:BACKGROUND:This study aimed to examine disparities in survival and associated factors for patients with nonsmall-cell lung cancer (NSCLC) and to determine whether racial disparities varied over time (1991-1995, 1996-1999, and 2000-2002). METHODS:The authors studied 70,901 patients aged>or=65 years with stage I-IV NSCL...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24521

    authors: Hardy D,Xia R,Liu CC,Cormier JN,Nurgalieva Z,Du XL

    更新日期:2009-10-15 00:00:00

  • Malignant melanoma metastatic to the breast: a report of seven cases diagnosed by fine-needle aspiration cytology.

    abstract:BACKGROUND:Metastases to the breast from extramammary primary tumors are uncommon. Malignant melanoma is one of the most common neoplasms to secondarily involve the mammary parenchyma. METHODS:Seven cases of malignant melanoma metastatic to the breast diagnosed by fine-needle aspiration biopsy are presented. RESULTS:...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19980625)84:3<160::aid-cnc

    authors: Cangiarella J,Symmans WF,Cohen JM,Goldenberg A,Shapiro RL,Waisman J

    更新日期:1998-06-25 00:00:00

  • Synovial sarcoma. A study of intensive chemotherapy in 14 patients with localized disease.

    abstract:BACKGROUND:The effectiveness of adjuvant chemotherapy in soft tissue sarcomas remains a matter of controversy. The authors reviewed their experience with 14 patients with localized disease treated with intensive doxorubicin-cisplatin-ifosfamide-based chemotherapy. METHODS:Fourteen patients with newly diagnosed nonmeta...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19931001)72:7<2161::aid-cncr2820

    authors: Kampe CE,Rosen G,Eilber F,Eckardt J,Lowenbraun S,Foster J,Forscher C,Selch M

    更新日期:1993-10-01 00:00:00

  • Treatment capacity required for full-scale implementation of lung cancer screening in the United States.

    abstract:BACKGROUND:Full-scale implementation of lung cancer screening in the United States will increase detection of early stages. This study was aimed at assessing the capacity required for treating those cancers. METHODS:A well-established microsimulation model was extended with treatment data from the National Cancer Data...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32026

    authors: Blom EF,Ten Haaf K,Arenberg DA,de Koning HJ

    更新日期:2019-06-15 00:00:00

  • Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care.

    abstract:BACKGROUND:Bioimpedance spectroscopy (BIS) has enabled the early identification of breast cancer-related lymphedema. In this study, differences in health service metrics and in the incidence of breast cancer-related lymphedema are evaluated in an early surveillance model of care compared with a traditional referral mod...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31873

    authors: Koelmeyer LA,Borotkanics RJ,Alcorso J,Prah P,Winch CJ,Nakhel K,Dean CM,Boyages J

    更新日期:2019-03-15 00:00:00

  • Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia.

    abstract::Systemic fungal infections are recognized at increasing frequency during the course of intensive therapy for acute leukemias and require parenteral antifungal treatment mostly by amphotericin B (ampho B) alone or in combination with 5-Fluorocytosine (5-FC). Because of the potential myelosuppressive side effects of 5-F...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19910701)68:1<9::aid-cncr2820680

    authors: Hiddemann W,Essink ME,Fegeler W,Zühlsdorf M,Sauerland C,Büchner T

    更新日期:1991-07-01 00:00:00